Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT02138292
Title	A Phase 1B Clinical Trial of Trametinib Plus Digoxin in Patients With Unresectable or Metastatic BRAF Wild-type Melanoma
Recruitment	Completed
Gender	both
Phase	Phase I
Variant Requirements	Yes
Sponsors	University of Texas Southwestern Medical Center
Indications	melanoma
Therapies	Digoxin + Trametinib
Age Groups:	adult
Covered Countries	USA